Reynalda K DeJesus

Title: Reynalda K DeJesus: Innovator in Cardiovascular Therapeutics

Introduction

Reynalda K DeJesus is a prominent inventor based in East Brunswick, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target renal outer medullary potassium channels. With a total of three patents to her name, her work has the potential to impact the treatment of various cardiovascular diseases.

Latest Patents

Among her latest patents, Reynalda has developed inhibitors of the renal outer medullary potassium channel. These compounds, described by the formula I and its pharmaceutically acceptable salts, serve as inhibitors of the ROMK (Kir1.1) channel. They may be utilized as diuretic and/or natriuretic agents, addressing medical conditions such as hypertension, heart failure, and chronic kidney disease. Additionally, these compounds are designed to manage conditions associated with excessive salt and water retention.

Career Highlights

Reynalda K DeJesus is currently associated with Merck Sharp & Dohme Corporation, where she continues her innovative work in pharmaceutical research. Her expertise in developing therapeutic agents has positioned her as a key player in the industry.

Collaborations

Throughout her career, Reynalda has collaborated with notable colleagues, including Alexander Pasternak and Haifeng Tang. These partnerships have further enhanced her research and development efforts in the field of cardiovascular therapeutics.

Conclusion

Reynalda K DeJesus is a trailblazer in the pharmaceutical industry, with her inventions paving the way for new treatments in cardiovascular health. Her dedication to innovation and collaboration underscores her significant role in advancing medical science.